The MHRA has outlined moves to deepen collaboration with the US on medical technology regulation, with initiatives to accelerate innovation, strengthen patient safety, and reduce transatlantic barriers to market access. At AdvaMed in San Diego, MHRA Chief Executive Lawrence Tallon highlighted the agency’s commitment to advancing global regulatory harmonisation and its strong partnership with the US Food and Drug Administration (FDA) during his fireside chat with Dr Michelle Tarver (Director, FDA…
Ben KempOctober 14, 2025